Skip to main content

856 publications

Name Date Type Actions

Monthly information regarding the total number of voting rights – February 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

05/03/2024 Voting rights

Monthly information regarding the total number of voting rights – January 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 

02/02/2024 Voting rights

Buyback programs – January 2024

Monthly communication regarding buyback programs

02/02/2024 Description of buyback programs

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

24/01/2024 Public releases

Monthly information regarding the total number of voting rights – December 2023

As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

04/01/2024 Voting rights

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

03/01/2024 Agenda

Buyback programs - November 2023

Monthly communication regarding buyback programs

04/12/2023 Description of buyback programs

Buyback programs - december 2023

Monthly communication regarding buyback programs

03/12/2023 Description of buyback programs

Buyback programs - october 2023

Monthly communication regarding buyback programs

06/11/2023 Description of buyback programs

Sales 3rd quarter 2023: 136M€

The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories.

26/10/2023 Public releases